Enrique Zudaire
Senior Vice President, Translational Sciences & Therapeutics Discovery Caribou Biosciences
Seminars
Tuesday 15th September 2026
Utilizing Targeted Gene Editing to Engineer Durable T-Cell Therapies
11:30 am
- Identifying the biological process behind T-cell downregulation
- Identifying and targeting negative regulators of T-cell function to disrupt biological downregulation pathways and preserve potency
- Applying gene editing strategies to intrinsically enhance T-cell durability by preventing functional exhaustion and loss of therapeutic activity
